Vertex Pharmaceuticals | Rentekostnader

Interest Expense On Debt Endring Dato
Arrowhead Research USD 5.37M 105K 2023-12
Gilead Sciences USD 252M 20M 2023-12
Insmed USD 21.57M 619K 2023-12
Roche Holding CHF 401M 53M 2023-06



Vertex Pharmaceuticals Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.